According to a study presented during the Academy of Managed Care Pharmacy's Nexus conference, industry professionals are hesitant to put their full weight behind patient-reported outcomes (PRO) data. The study, which was funded by pharmaceutical company Pfizer, included lengthy phone interviews […]
SHYFT’S Berger Talks Path to Stronger RWE
SHYFT Analytics Real World Evidence Advisory Board Chair Marc Berger in an interview discussed how the use of real-world evidence continues to evolve in the current health care landscape, and his recent efforts to ensure more reliable data. Berger, who has more than 25 years in the health industry, […]
PhRMA’s Lori Reilly Testifies at Senate Hearing
Pharmaceutical Research and Manufacturers of America Executive Vice President for Policy, Research and Membership Lori Reilly testified Tuesday at a Senate Committee on Health, Education Labor and Pensions hearing about drug delivery systems and drug pricing. PhRMA provided excerpts from Reilly's […]
The Future of Market Access in the U.S.
When it comes to the affordability challenge, have payers and drugmakers reached a stalemate in the U.S.? Pricing wars continue to rage, pharma initiatives are having lackluster impact, and payers are still not happy. At the same time, U.S. President Donald Trump is waxing lyrical about sweeping […]
Kristensen, Reed and Watkins Discuss HTA
Science and Policy Managing Director Finn Kirstensen, Duke Clinical Research Institute Professor Shelby Reed and Premera Blue Cross Pharmacy Manager John Watkins discussed health technology assessments (HTA) during the Academy of Managed Care Pharmacy's Nexus 2017. Click here to read more on AMCP's […]
States Putting Foot Down on High Drug Prices
Some states across the U.S. have grown tired of waiting for congressional action in Washington to curb high drug prices, so they've begun taking the fight directly to the pharmaceutical industry. Ed Silverman with STAT News gives a rundown on some of the steps taken by eight states including […]
New Avella Program Aims to Engage, Support Patients
Avella has announced the introduction of a new patient support program, NurseConnect, designed to engage and educate individuals taking powerful specialty drugs to manage their health conditions. Avella’s highly-trained nurses deliver outreach through a variety of modalities, including video, […]
Moving Forward with HCEI, FDA’s 2017 Guidance
Via Academy of Managed Care Pharmacy: "As part of the 21st Century Cures Act, the FDA released a draft guidance in early 2017 on approved communication of healthcare economic information (HCEI) for prescription drugs to payers, formulary committees, or other similar entities with knowledge and […]
Kim Woofter Talks Data, Care Delivery
Executive Vice President of Strategic Alliances and Practice Innovation at the Advanced Centers for Care Kim Woofter said in five years she hopes to see value-based care as a requirement and more robust data for care delivery. Woofter made the comments during a brief interview with the American […]
Budget Impact Models and Why They’re Important
Three speakers at the Academy of Managed Care Pharmacy's AMCP Nexus meeting discussed how the role of a budget impact analysis has become increasingly important prior to implementing a public health intervention. University of Maryland School of Pharmacy in Baltimore Professor Daniel Mulls, […]
Professor Li Discusses Oncology Pipeline at AMCP Nexus
University of New England College of Pharmacy Professor Edward Li provided an overview of the drug oncology pipeline during a presentation at the Academy of Managed Care Pharmacy's Nexus 2017 conference. According to AMCP, Li discussed three major drugs which are poised for approval in 2018: […]
Senate Health Committee Holds Hearing on Drug Prices
The Senate Health, Education, Labor and Pensions Committee on Tuesday held a hearing on drug prices, which turned into a back and forth between U.S. lawmakers and pharmaceutical manufacturers. The full hearing can be viewed on the committee's website here. […]
Report: Hospitals Mark Up Meds Almost 500%
According to a report from the Moran Company, hospitals mark up medicine prices by roughly 500 percent on average. The analysis was commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). Hospitals also receive more than 250 percent in returns on their drug purchases […]
Peeples, Drake to Host HEOR, RWE Writing Classes Nov. 2
On Thursday, November 2, 2:00 - 3:30 PM, Patti Peeples, RPh, PhD, of HealthEconomics.Com and Tom Drake, MA, CMPP, of Global Outcomes Group will teach a 1.5-hour hands-on and engaging session on Intermediate Health Economics and Outcomes Research (HEOR) and Real-World Evidence (RWE): Elements, […]
Trump’s Drug Czar Nominee Withdraws
President Donald Trump on Tuesday announced his nominee to head the Office of National Control Policy has pulled his name from consideration. Modern Healthcare reports Trump on Twitter called Rep. Tom Marino "a fine man and a great congressman." Click here to read the full report on Modern […]
GOP, Dems Reach Deal to Fund Health Subsidies
On the heels of President Donald Trump's announcement that the government would stop funding cost-sharing reduction payments, Republicans and Democrats say they've negotiated a 2-year proposal to keep the subsidies afloat. Sens. Lamar Alexander and Patty Murray reached the deal Tuesday, Fierce […]
Patient-Centered Endpoints in CV Trials Gaining Momentum
Clinical trial designs focusing on more patient-centered endpoints are picking up steam in the industry, focusing more on factors ranging from quality of life to out-of-pocket expenses. Dr. Sean Collins with the Vanderbilt University Medical Center along with his co-authors made the case for a […]
FDA Plans New Patient Affairs Team
Food and Drug Administration Commissioner Scott Gottlieb on Oct. 11 announced the agency will create a new patient affairs team which will coordinate "certain agency-wide and multi-center projects related to patient engagement." Gottlieb made the announcement during the first meeting of the Patient […]
Getting Around the Paywall: ResearchGate to Remove Millions of Journal Articles
Free access to journal articles via ResearchGate, a network often likened to Facebook for scientists, may be quickly disappearing, Nature reports, due to a lawsuit filed by Elsevier and the American Chemical Society to try to prevent copyrighted material from appearing on ResearchGate. For years, […]
Trump Order Aims to Help Small Business, Trade Groups
President Donald Trump on Thursday signed an executive order which would allow small businesses and trade groups to form associations to buy out-of-state health policies, MedPage Today reports. Per the order, the Secretary of Labor will mull new methods by which to bolster access to association […]
Gottlieb Aims to Hold Tight at FDA
As President Donald Trump continues the search for a new Health and Human Services secretary, pharmaphorum reports current Food and Drug Administration Commissioner Scott Gottlieb says he'd rather hold tight. "I feel like I want to continue to follow through on policies we've put out, and it's […]
Cochrane Offers New Interactive Learning Course
Developed by world-leading experts, Cochrane's new interactive learning course, "Conducting an Intervention Review," provides over 10 hours of self-directed learning on the complete systematic review process for both new and experienced review authors. Cochrane Interactive Learning is aimed […]
Cut Subsidies Expected to Create Higher Premiums
Insurers say without cost-sharing reduction (CSR) payments they will have to hike premiums for some marketplace plans, according to a Fierce Healthcare report. Some insurers also say the lack of CSR payments will force them out of the market entirely. President Donald Trump's White House announced […]
New Book: “Fixing Medical Prices”
Medical care prices in the United States are not only the most expensive in the world, but there are wide variations in what physicians are paid. Doctors at the frontlines of medical care who manage complex conditions argue that they receive disproportionately lower fees than physicians performing […]
MSPBA Candidate Talks Accreditation in Specialty Pharmacy
University of Pittsburgh Masters of Science in Pharmacy Business Administration candidate Alex Toman gives a rundown on accreditation in specialty pharmacy. Click here to read Toman's write up on Specialty Pharmacy Times. […]
MAPS 2018 Keynote Speaker Announced
The Medical Affairs Professional Society (MAPS) on Thursday announced Academy of Managed Care Pharmacy (AMCP) Director of Pharmacy and Regulatory Affairs Dr. Soumi Saha will be the keynote speaker at its Feb. 26 meeting in Miami, Florida. According to a press release, Saha will discuss health care […]
New Syndicated Report: The Future of Market Access in Europe
"The Future of Market Access in Europe" takes a step into the ongoing debates about the challenges and obstacles still facing market access in Europe. "Payers and health-technology assessment agencies at multiple levels of healthcare systems have a growing influence on market-access conditions for […]
California Governor Signs Drug Transparency Legislation
The pharmaceutical industry will be a little more transparent in California after Gov. Jerry Brown on Monday signed a bill aimed at combating rising drug costs. Click here to read the report on STAT News. (Paid subscription required) […]
‘Best-Price Rule’ Versus Value-Based Care
Some concern has arisen over Medicaid's "best-price rule" and how it hinders progress toward more novel, value-based agreements. A Washington University in St. Louis drug pricing and regulation expert is attempting to dispel those concerns. "The best-price rule is not as serious a problem as drug […]
What Thaler’s Nobel Means for Diabetes Care
University of Chicago's Richard Thaler's recent Nobel Prize award for his work in economic sciences carries broad implications for personal health care, the American Journal of Managed Care reports. Thaler and Harvard legal scholar Cass Sunstein in 2008 released "Nudge: Improving Decisions About […]
